Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity

被引:45
作者
Mohamed, Mohamed-Eslam F. [1 ]
Tseng, Tiffany [1 ]
Frye, Reginald E. [1 ]
机构
[1] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA
关键词
Green tea; EGCG; milk thistle; UGT1A1; estradiol glucuronidation; inhibition; IN-VITRO; UDP-GLUCURONOSYLTRANSFERASE; LIQUID-CHROMATOGRAPHY; DRUG INTERACTIONS; GLUCURONIDATION; ESTRADIOL; PHARMACOKINETICS; CONJUGATION; METABOLISM; RALOXIFENE;
D O I
10.3109/00498254.2010.505669
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Commonly used herbal supplements were screened for their potential to inhibit UGT1A1 activity using human liver microsomes. Extracts screened included ginseng, echinacea, black cohosh, milk thistle, garlic, valerian, saw palmetto, and green tea epigallocatechin gallate (EGCG). Estradiol-3-O-glucuronide (E-3-G) formation was used as the index of UGT1A1 activity. 2. All herbal extracts except garlic showed inhibition of UGT1A1 activity at one or more of the three concentrations tested. A volume per dose index (VDI) was calculated to estimate the volume in which the daily dose should be diluted to obtain an IC50-equivalent concentration. EGCG, echinacea, saw palmetto, and milk thistle had VDI values >2.0L per dose unit, suggesting a higher potential for interaction. 3. Inhibition curves were constructed for EGCG, echinacea, saw palmetto, and milk thistle. IC50 values were (mean +/- SE) 7.8 +/- 0.9, 211.7 +/- 43.5, 55.2 +/- 9.2, and 30.4 +/- 6.9 mu g/ml for EGCG, echinacea, saw palmetto, and milk thistle extracts, respectively. 4. Based on our findings, inhibition of UGT1A1 by milk thistle and EGCG and to a lesser extent by echinacea and saw palmetto is plausible, particularly in the intestine where higher extract concentrations are anticipated. Further clinical studies are warranted.
引用
收藏
页码:663 / 669
页数:7
相关论文
共 35 条
  • [1] Sensitive liquid chromatographic method using fluorescence detection for the determination of estradiol 3-and 17-glucuronides in rat and human liver microsomal incubations: formation kinetics
    Alkharfy, KM
    Frye, RF
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 774 (01): : 33 - 38
  • [2] [Anonymous], 2007, NUTR BUS J
  • [3] [Anonymous], 2008, COMPLEMENTARY ALTERN
  • [4] Potential of pharmacokinetic profiling for detecting herbal interactions with drugs
    Butterweck, Veronika
    Derendorf, Hartmut
    [J]. CLINICAL PHARMACOKINETICS, 2008, 47 (06) : 383 - 397
  • [5] Copeland R., 2005, EVALUATION ENZYME IN, V1st
  • [6] Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases
    Court, MH
    [J]. PHASE II CONJUGATION ENZYMES AND TRANSPORT SYSTEMS, 2005, 400 : 104 - 116
  • [7] The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial
    Cummings, SR
    Eckert, S
    Krueger, KA
    Grady, D
    Powles, TJ
    Cauley, JA
    Norton, L
    Nickelsen, T
    Bjarnason, NH
    Morrow, M
    Lippman, ME
    Black, D
    Glusman, JE
    Costa, A
    Jordan, VC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23): : 2189 - 2197
  • [8] Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide
    D'Andrea, V
    Pérez, LM
    Pozzi, EJS
    [J]. LIFE SCIENCES, 2005, 77 (06) : 683 - 692
  • [9] Doerge DR, 2000, DRUG METAB DISPOS, V28, P298
  • [10] Trends in alternative medicine use in the United States, 1990-1997 - Results of a follow-up national survey
    Eisenberg, DM
    Davis, RB
    Ettner, SL
    Appel, S
    Wilkey, S
    van Rompay, M
    Kessler, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18): : 1569 - 1575